Cardiac function as related to adrenergic activity in hypertensive left ventricular hypertrophy
Related Experiment Videos
Insights
The sympathetic nervous system influences cardiac changes in hypertension. Adrenergic factors, particularly noradrenaline, are linked to left ventricular hypertrophy and impaired cardiac function in hypertensive patients.
Area of Science:
- Cardiology
- Hypertension Research
- Neurocardiology
Background:
- Cardiac anatomical and functional changes in hypertension are complex.
- Sympathetic nervous system activity is a potential modulator of cardiac performance and anatomy in hypertensive individuals.
Purpose of the Study:
- To investigate the role of adrenergic factors in cardiac hypertrophy and function in hypertension.
- To explore the relationship between sympathetic activity, left ventricular mass, and cardiac performance in hypertensive patients.
Main Methods:
- Review of animal studies and clinical data from hypertensive patients.
- Analysis of plasma catecholamine levels, including noradrenaline.
- Assessment of cardiac performance changes following beta-adrenergic blockade.
Main Results:
- Animal studies suggest adrenergic factors contribute to left ventricular hypertrophy.
- Hypertensive patients with left ventricular hypertrophy exhibit higher plasma catecholamines, correlating with left ventricular mass.
- Reduced cardiac performance after beta blockade is linked to baseline noradrenaline levels.
- Impaired beta-adrenergic stimulation response is observed in hypertensive subjects.
Conclusions:
- Sympathetic nervous system activity, specifically adrenergic factors, plays a significant role in cardiac remodeling and dysfunction in hypertension.
- Noradrenaline levels are a key indicator of cardiac changes and functional impairment in hypertensive patients.
Abstract:
Studies in experimental animals and in hypertensive patients have shown that changes in cardiac anatomy and function are not just a simple consequence of the increased pressure load. The activity of the sympathetic nervous system is one of the factors that may influence cardiac performance and also, possibly, the cardiac anatomy of hypertensive patients. Animal studies have strongly suggested a possible role of adrenergic factors in the development of left ventricular hypertrophy. In man, plasma catecholamines are usually higher in hypertensive patients with left ventricular hypertrophy, and a correlation between left ventricular mass and plasma noradrenaline has also been observed. The decrease of cardiac performance after acute beta blockade has been found to be directly related to basal plasma noradrenaline concentration. An impaired response to beta-adrenergic stimulation has been reported in hypertensive animals and has been confirmed in hypertensive patients with left ventricular hypertrophy.